Op-Eds

Op-Ed

SCOTUS Weakened Our Patent System. Congress Can Fix It.

Op-Ed

Congress Should Pass Tillis-Coons Patent Eligibility Bill

Op-Ed

Protect the value of American invention

Op-Ed

Biden’s cancer moonshot will miss without intellectual property

Op-Ed

Scapegoating Patents Won’t Lower Drug Prices

Op-Ed

The Law is Clear: There’s No Legal Authority to Control Prices Via Bayh-Dole

Op-Ed

America’s 21st Century Sputnik Moment

Op-Ed

Removing patent rights to lower drug costs is dangerous precedent

Op-Ed

U.S. patent system weakens: Protect IP to keep American tech at the top

Op-Ed

China’s formidable technology challenge

Scroll to Top